Cited 0 times in 
Cited 0 times in 
An Open-Label, Multicentre, Phase 2 Study Of Trastuzumab Deruxtecan In Patients With HER2-Expressing Solid Tumours: DESTINY-PanTumor02 Part 2
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 이정윤 | - |
| dc.date.accessioned | 2026-01-29T06:25:47Z | - |
| dc.date.available | 2026-01-29T06:25:47Z | - |
| dc.date.issued | 2025-02 | - |
| dc.identifier.issn | 1744-3121 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/210327 | - |
| dc.description.abstract | 10.1016/j.ijgc.2024.101598 | - |
| dc.language | English | - |
| dc.publisher | Blackwell Pub. | - |
| dc.relation.isPartOf | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | An Open-Label, Multicentre, Phase 2 Study Of Trastuzumab Deruxtecan In Patients With HER2-Expressing Solid Tumours: DESTINY-PanTumor02 Part 2 | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Obstetrics and Gynecology (산부인과학교실) | - |
| dc.contributor.googleauthor | Ana Oaknin | - |
| dc.contributor.googleauthor | Jung-Yun Lee | - |
| dc.contributor.googleauthor | Vicky Makker | - |
| dc.contributor.googleauthor | Do-Youn Oh | - |
| dc.contributor.googleauthor | Chiedozie Anoka | - |
| dc.contributor.googleauthor | Lindsey Jung | - |
| dc.contributor.googleauthor | Soham Puvvada | - |
| dc.contributor.googleauthor | João Simões | - |
| dc.contributor.googleauthor | Funda Meric-Bernstam | - |
| dc.contributor.localId | A04638 | - |
| dc.relation.journalcode | J01123 | - |
| dc.identifier.eissn | 1744-313X | - |
| dc.contributor.alternativeName | Lee, Jung-Yun | - |
| dc.contributor.affiliatedAuthor | 이정윤 | - |
| dc.citation.volume | 35 | - |
| dc.citation.number | 2 Suppl.1 | - |
| dc.citation.startPage | 101598 | - |
| dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, Vol.35(2 Suppl.1) : 101598, 2025-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.